Pediatric cancer recurrence is a pressing concern that affects countless families navigating the complexities of childhood cancers, particularly gliomas.Recent advancements in artificial intelligence (AI) within pediatric oncology have significantly enhanced our ability to predict cancer relapse, marking a pivotal shift in treatment approaches.